The Titrated Mannitol Improved Central [99mTc] Tc TRODAT-1 Uptake in an Animal Model—A Clinically Feasible Application

Author:

Chang Kang-Wei1ORCID,Chang Po-Ling2,Tsai Chi-Jung3,Tsai Ya-Ju3,Wu Ping-Hsiu45,Lee Hsin-Lun45,Lai Yu-Hua6,Wong Ching-Yee Oliver7,Huang Wen-Sheng38ORCID

Affiliation:

1. Taipei Neuroscience Institute & Laboratory Animal Center, Taipei Medical University, Taipei 11048, Taiwan

2. Departments of Nuclear Medicine, Changhua Christian Hospital, Changhua 50006, Taiwan

3. Departments of Nuclear Medicine, Taipei Medical University Hospital, Taipei 11048, Taiwan

4. Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11048, Taiwan

5. Department of Radiation Oncology, Taipei Medical University Hospital, Taipei 11048, Taiwan

6. Department of Neurology, Cheng Hsin General Hospital, Taipei 11283, Taiwan

7. Department of Radiology, University of Southern California, Los Angeles, CA 90007, USA

8. Department of Nuclear Medicine, Cheng Hsin General Hospital, Taipei 11283, Taiwan

Abstract

[99mTc]Tc TRODAT-1 is a widely used single photon emission tomography (SPECT) radiopharmaceutical in Asian practice for early detection of central dopaminergic disorders. However, its imaging quality remains sub-optimal. To overcome this problem, mannitol, an osmotic agent was used to observe its effect on improving striatal [99mTc]Tc TRODAT-1 uptake in rat brain by titrated human dosages to investigate a clinically feasible way to improve human imaging quality. [99mTc]Tc TRODAT-1 synthesis and quality control were performed as described. Sprague–Dawley rats were used for this study. The animal in vivo nanoSPECT/CT and ex vivo autoradiography were employed to observe and verify the striatal [99mTc]Tc TRODAT-1 uptake in rat brains using clinically equivalent doses (i.e., 0, 1 and 2 mL groups, each n = 5) of mannitol (20% w/v, equivalent to 200 mg/mL) by an intravenous administration. Specific binding ratios (SBRs) were calculated to express the central striatal uptake in different experimental groups. In the NanoSPECT/CT imaging, the highest SBRs of striatal [99mTc]Tc TRODAT-1 were reached at 75–90 min post-injection. The averaged striatal SBRs were 0.85 ± 0.13 (2 mL normal saline, the control group), 0.94 ± 0.26 (1 mL mannitol group) and 1.36 ± 0.12 (2 mL mannitol group, p < 0.01 which were significantly different than the control as well as 1 mL mannitol groups (p < 0.05). The SBRs from ex vivo autoradiography also showed a comparable trend of the striatal [99mTc]Tc TRODAT-1 uptake in the 2 mL, 1 mL mannitol and the control groups (1.76 ± 0.52, 0.91 ± 0.29, and 0.21 ± 0.03, respectively, p < 0.05). No remarkable changes of vital signs were found in the mannitol groups and the controls. Pre-treated mannitol revealed a significant increase of the central striatal [99mTc]Tc TRODAT-1 uptake in a rat model which not only enabled us to perform pre-clinical studies of dopaminergic related disorders but also provided a potential way to further optimize image quality in clinical practice.

Funder

Taipei Medical University, Taiwan

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Reference39 articles.

1. Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum: Implications for human Parkinson’s disease;Reader;Neurochem. Int.,1999

2. Nicotine effects on learning in zebrafish: The role of dopaminergic systems;Eddins;Psychopharmacology,2008

3. 18F-FDOPA PET imaging of brain tumors: Comparison study with 18F-FDG PET and evaluation of diagnostic accuracy;Chen;J. Nucl. Med.,2006

4. Ex vivo evaluation of N-(3-[18F]fluoropropyl)-2 beta-carbomethoxy-3 beta-(4-fluorophenyl)nortropane in rats;Koivula;Nucl. Med. Biol.,2008

5. [99mTc]TRODAT-1: A novel technetium-99m complex as a dopamine transporter imaging agent;Kung;Eur. J. Nucl. Med.,1997

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3